Search hospitals > Missouri > Lees Summit
Saint Luke's East - Lee's Summit
Claim this profileLees Summit, Missouri 64086
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
184 reported clinical trials
10 medical researchers
Summary
Saint Luke's East - Lee's Summit is a medical facility located in Lees Summit, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Saint Luke's East - Lee's Summit is involved with conducting 184 clinical trials across 310 conditions. There are 10 research doctors associated with this hospital, such as Janakiraman Subramanian, Addison R. Tolentino, Rakesh Gaur, and Shahzad Raza, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Janakiraman SubramanianSaint Luke's Hospital of Kansas City5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
20 drugs studied
Addison R. TolentinoSaint Luke's Hospital of Kansas City10 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
14 drugs studied
Rakesh GaurResearch Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
7 reported clinical trials
22 drugs studied
Shahzad Raza, MDSaint Luke's Hospital of Kansas City9 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Clinical Trials running at Saint Luke's East - Lee's Summit
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Pancreatic Carcinoma
Cancer
Meningioma
Pancreatic Cancer
Multiple Myeloma
ALK Gene Rearrangement
Squamous Cell Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Luke's East - Lee's Summit?
Saint Luke's East - Lee's Summit is a medical facility located in Lees Summit, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Saint Luke's East - Lee's Summit is involved with conducting 184 clinical trials across 310 conditions. There are 10 research doctors associated with this hospital, such as Janakiraman Subramanian, Addison R. Tolentino, Rakesh Gaur, and Shahzad Raza, MD.